Device
Emdogain
Emdogain is a medical device with 4 clinical trials. Historical success rate of 75.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_4
3
75%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution3 total trials
Phase 4Post-market surveillance
3(100.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Terminated(1)
Detailed Status
Completed3
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
Phase 4
Trials by Phase
Phase 43 (100.0%)
Trials by Status
completed375%
terminated125%
Recent Activity
0 active trials
Showing 4 of 4
terminated
Safety and Efficacy of Periodontal Surgery in Supra-alveolar-type Defects With or Without Straumann® Emdogain
NCT01614925
completedphase_4
Xenogenous Collagen Matrix Graft With or Without Enamel Matrix Proteins Derivative for Root Coverage
NCT02456337
completedphase_4
Regenerative Surgical Treatment of Peri-implantitis
NCT02500654
completedphase_4
Study on Regenerative Treatment of Intra-bony Defects
NCT00757159
Clinical Trials (4)
Showing 4 of 4 trials
NCT01614925
Safety and Efficacy of Periodontal Surgery in Supra-alveolar-type Defects With or Without Straumann® Emdogain
NCT02456337Phase 4
Xenogenous Collagen Matrix Graft With or Without Enamel Matrix Proteins Derivative for Root Coverage
NCT02500654Phase 4
Regenerative Surgical Treatment of Peri-implantitis
NCT00757159Phase 4
Study on Regenerative Treatment of Intra-bony Defects
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4